The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Future of Pediatric Rheumatology Grounded in Evolution of Childhood Arthritis and Rheumatology Research Alliance

The Future of Pediatric Rheumatology Grounded in Evolution of Childhood Arthritis and Rheumatology Research Alliance

December 15, 2016 • By Yukiko Kimura, MD, & Laura E. Schanberg, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Pediatric rheumatology was formally recognized as a specialty in 1991 by the American Board of Pediatrics.

Pediatric rheumatology was formally recognized as a specialty in 1991 by the American Board of Pediatrics.
Yukiko Kimura, MD

Pediatric rheumatology was formally recognized as a specialty in 1991 by the American Board of Pediatrics. Prior to this time, children with rheumatic diseases were treated by a hodgepodge of providers. In addition to providers who had training as pediatric rheumatologists, general pediatricians, adult rheumatologists, allergist-immunologists, orthopedists, pediatric infectious disease specialists and others treated children with rheumatic diseases. As a result, there was little advocacy or research in the field and little consistency in treatment approaches.

You Might Also Like
  • 2013 ACR/ARHP Annual Meeting: Better Care for Pediatric Rheumatology Patients On Horizon
  • Pediatric Rheumatology Research Highlights Successful Approaches to Manage Juvenile Rheumatic Diseases
  • California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis
Explore This Issue
December 2016

It was not until the late 20th century, with clear successes treating children with cancer through the development of several pediatric oncology networks working to standardize, protocolize and study treatments for all children with specific cancers, that the importance of evidence-based treatment approaches was recognized by healthcare providers and families.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The passage of national legislation mandating the study of new pharmaceuticals in children as part of FDA approval packages and the success of methotrexate and later anti-TNF agents in the treatment of rheumatoid arthritis also highlighted the need and opportunities for ongoing clinical and translational research in the field of pediatric rheumatology.

CARRA: The Beginning (2000–2007)

The Childhood Arthritis & Rheumatology Research Alliance (CARRA) began in 2000 as a grassroots initiative among a small number of pediatric rheumatologists in the U.S. and Canada seeking to establish an inclusive, collaborative research network. The overall mission and supporting guiding principles that outlined scientific, leadership and operational elements were crafted at a meeting in 2001, and the initial scientific agenda and criteria for studies to be undertaken by the network were established in 2002.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

CARRA was envisioned as a network that would enable widespread research participation, thereby ensuring the future of academic pediatric rheumatology, which was endangered at the time. Three crucial components were identified at the meeting that continue to form the bedrock of the current organization:

  1. An organizational structure that includes rotating leadership positions and a steering committee elected by members to specific terms with term limits;
  2. Disease-based research committees led by rotating elected committee chairs forming the heart of the organization and encompassing the breadth of diseases and interests within the pediatric rheumatology community; and
  3. Commitment to include all pediatric rheumatology investigators and sites to further research accessibility and make it possible for all children diagnosed with rheumatic diseases and their families to participate in research studies.

The annual face-to-face scientific working meeting then became a crucial component of CARRA’s operation, fostering a culture of collaboration and research among the entire pediatric rheumatology community.

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Professional Topics, Profiles Tagged With: CARRA, Childhood Arthritis & Rheumatology Research Alliance, future, History, patient care, Pediatric, Profile, rheumatologyIssue: December 2016

You Might Also Like:
  • 2013 ACR/ARHP Annual Meeting: Better Care for Pediatric Rheumatology Patients On Horizon
  • Pediatric Rheumatology Research Highlights Successful Approaches to Manage Juvenile Rheumatic Diseases
  • California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis
  • Growing Up Confident with Juvenile Idiopathic Arthritis

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Patient & Caregiver Resources

Find a rheumatology provider. Learn about your condition and how to live with it. English and Spanish language resources.

View Patient & Caregiver Resources »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)